Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, Buckley PF. Pillai A, et al. Among authors: schooler nr. Schizophr Res. 2018 Mar;193:263-268. doi: 10.1016/j.schres.2017.06.059. Epub 2017 Jul 19. Schizophr Res. 2018. PMID: 28734907
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.
Buckley PF, Schooler NR, Goff DC, Hsiao J, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz AJ, Miller del D, Severe JB, Wilson DR, Ames D, Bustillo J, Mintz J, Kane JM; PROACTIVE Study. Buckley PF, et al. Among authors: schooler nr. Schizophr Bull. 2015 Mar;41(2):449-59. doi: 10.1093/schbul/sbu067. Epub 2014 May 27. Schizophr Bull. 2015. PMID: 24870446 Free PMC article. Clinical Trial.
Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study.
Buckley PF, Schooler NR, Goff DC, Kopelowicz A, Lauriello J, Manschreck TC, Mendelowitz A, Miller DD, Wilson DR, Ames D, Bustillo JR, Kane JM, Looney SW. Buckley PF, et al. Among authors: schooler nr. Psychiatr Serv. 2016 Dec 1;67(12):1370-1372. doi: 10.1176/appi.ps.201500466. Epub 2016 Aug 1. Psychiatr Serv. 2016. PMID: 27476806 Clinical Trial.
Lack of ECT effects on clozapine plasma levels in patients with treatment-resistant schizophrenia: Pharmacokinetic evidence from a randomized clinical trial.
Schoretsanitis G, Mendelowitz A, Malur C, Braga RJ, Schooler NR, John M, de Leon J, Kane JM, Petrides G. Schoretsanitis G, et al. Among authors: schooler nr. Schizophr Res. 2020 Apr;218:309-311. doi: 10.1016/j.schres.2020.02.008. Epub 2020 Feb 24. Schizophr Res. 2020. PMID: 32107101 Clinical Trial. No abstract available.
The Mount Sinai conference on the pharmacotherapy of schizophrenia.
Marder SR, Essock SM, Miller AL, Buchanan RW, Davis JM, Kane JM, Lieberman J, Schooler NR. Marder SR, et al. Among authors: schooler nr. Schizophr Bull. 2002;28(1):5-16. doi: 10.1093/oxfordjournals.schbul.a006926. Schizophr Bull. 2002. PMID: 12047022 Review.
Response to Saraga.
Robinson DG, Schooler NR, Kane JM. Robinson DG, et al. Among authors: schooler nr. Am J Psychiatry. 2015 Jun;172(6):588. doi: 10.1176/appi.ajp.2015.14121589r. Am J Psychiatry. 2015. PMID: 26029809 No abstract available.
Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program.
Rosenheck R, Leslie D, Sint K, Lin H, Robinson DG, Schooler NR, Mueser KT, Penn DL, Addington J, Brunette MF, Correll CU, Estroff SE, Marcy P, Robinson J, Severe J, Rupp A, Schoenbaum M, Kane JM. Rosenheck R, et al. Among authors: schooler nr. Schizophr Bull. 2016 Jul;42(4):896-906. doi: 10.1093/schbul/sbv224. Epub 2016 Jan 31. Schizophr Bull. 2016. PMID: 26834024 Free PMC article. Clinical Trial.
224 results